Related Experiment Video
Updated: Jan 7, 2026

07:20
Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies
Published on: January 28, 2014
37.1K
Biomarkers
Harsh Bhasin1,2, Nishant Rana3, Vishal Deshwal4
1Bennett University, Greater Noids, Uttar Prdesh, India.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|December 24, 2025
Summary
This study predicts Mild Cognitive Impairment (MCI) to Alzheimer's disease conversion using brain region analysis. The novel auto-encoder graph method achieved a 95.4% F-score, outperforming existing approaches.
Area of Science:
- Neuroscience
- Medical Imaging
- Machine Learning
Background:
- Mild Cognitive Impairment (MCI) is a precursor to Alzheimer's disease.
- Gray matter decay in specific brain regions (Hippocampus, Entorhinal cortex, Cerebral cortex, Frontal lobe, Temporal lobe, Parietal lobe, Occipital lobe) is linked to cognitive decline.
- Accurate prediction of MCI conversion is crucial for timely intervention.
Purpose of the Study:
- To develop an improved prediction model for MCI conversion to Alzheimer's disease.
- To identify key brain regions and their interconnections involved in MCI progression.
- To leverage novel feature extraction techniques for enhanced diagnostic accuracy.
Main Methods:
- A novel auto-encoder based method was used for feature extraction from seven key brain regions.
- A graph representation was constructed, with nodes as brain regions and edge weights based on feature similarity.
- Graph features were flattened into a 1-D vector for classification using Support Vector Machine (SVM) with linear kernel and forward feature selection.
Main Results:
- The method was validated on 75 MCI-Converts and 112 MCI-Non Converts from the Alzheimer's Disease Neuroimaging Initiative (ADNI) dataset.
- The classification achieved a high F-score of 95.4%.
- This performance surpasses current state-of-the-art methods in predicting MCI conversion.
Conclusions:
- The proposed method offers region-specific insights into MCI conversion prediction.
- It enables network analysis of brain region interactions, revealing underlying mechanisms of MCI progression.
- The approach demonstrates high accuracy, generalizability, and potential for clinical application.
Related Concept Videos
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
749
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
749
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
516
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
516

